Example: Heart Attack
Clinical Trials on Nasopharyngitis
Total 2 results
-
NCT05314933RecruitingConditions: Acute Nasopharyngitis
-
NCT04797936CompletedConditions: Covid19, Nasopharyngitis, Anosmia, Fever, Myalgia, Cough, Nasal Congestion
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Medical Conditions
- COVID-19
- Monkeypox
- Anemia, Diamond-Blackfan
- Cystic Fibrosis
- Dystonic Disorders
- Embryonal Carcinoma
- Factor X Deficiency
- Hemangioma, Cavernous
- Hemorrhoids
- Mixed Tumor, Mullerian
- Neoplasms, Germ Cell and Embryonal
- Pneumoconiosis
- Spinocerebellar Ataxia 30
- Stevens-Johnson Syndrome/toxic Epidermal Necrolysis
- Vasa Previa
- View Full List
Sponsors and Collaborators
- Canadian Association of Radiation Oncology
- Charles Darwin University
- DreaMed
- Favrille
- Firuzgar hospital affiliated to Iran University of Medical Sciences
- Ingalfarma SpA
- Lite Run Inc.
- Naturalpha
- SFJ Pharmaceuticals, Inc.
- Santa Maria alla Gruccia Hospital
- SpotOn Therapeutics Ltd.
- The California Table grape Commission
- University Medicine Greifswald
- View Full List
Drug Interventions
- Anti-VEGF agent
- Arginine Butyrate
- Buprenorphine and naloxone
- Camrelizumab + famitinib
- Duloxetine 60mg Reference Product Enteric Coated Granules
- GS-9190 placebo
- JARDIANCE®
- Levobupivacaine Hydrochloride 2.5 MG/ML
- Oral ibuprofen
- Pramlintide Acetate
- SCIO-469 and bortezomib
- Verteporfin
- Zofin
- View Full List